Target intelligence / Profile preview

Beta-1,3-D-glucan synthase catalytic subunit (Fks1)

Target
Fks1
Molecular classification
Enzyme, Glycosyltransferase, Integral membrane protein
01

Overview

The fungal beta-1,3-D-glucan synthase catalytic subunit is a critical enzyme complex component responsible for the synthesis of beta-1,3-glucan, the primary structural polysaccharide in the fungal cell wall (UniProt P38631). Encoded primarily by the FKS1 gene (and its paralogs FKS2 and FKS3), this large integral membrane protein catalyzes the transfer of glucose from UDP-glucose to a growing glucan chain and facilitates its translocation to the extracellular space (NIH, 1.4.4). Because mammalian cells lack a cell wall and do not produce beta-1,3-glucan, this enzyme is a highly selective and effective target for antifungal agents (Wikipedia). Echinocandins, such as caspofungin and micafungin, and the triterpenoid ibrexafungerp act as non-competitive inhibitors of this subunit, leading to weakened cell walls, osmotic lysis, and fungal death (NIH, 1.3.1). Clinical resistance to these drugs is often mediated by specific mutations in hotspot regions of the FKS1 or FKS2 genes, which decrease the enzyme's sensitivity to inhibition (NIH, 1.3.5).

Other names
Fks1p1,3-beta-glucan synthase component FKS11,3-beta-D-glucan-UDP glucosyltransferaseGls1Gsc1Cnd1Cwh53Etg1Pbr1
02

Mechanism of action

Non-competitive inhibition of the 1,3-beta-D-glucan synthase enzyme, which prevents the synthesis of beta-1,3-glucan, a vital structural component of the fungal cell wall, leading to osmotic instability and cell lysis (NIH, 1.3.1).

03

Biological functions

Cell wall synthesis(1->3)-beta-D-glucan biosynthetic processCell wall maintenanceFungal-type cell wall polysaccharide biosynthetic process
04

Disease associations

InfectionCandidiasisAspergillosisPneumocystis pneumonia
05

Safety considerations

HepatotoxicityInfusion-related reactions (histamine release)Development of drug resistance via target mutationsLimited oral bioavailability for most classes
06

Interacting drugs

Caspofungin

4 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BG) serum levelsFKS1 gene mutationsFKS2 gene mutations

Beyond the preview

Go deeper on Beta-1,3-D-glucan synthase catalytic subunit (Fks1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,3-D-glucan synthase catalytic subunit (Fks1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call